Swiss Medical Devices for Autologous Regenerative Medicine: From Innovation to Clinical Validation

被引:7
|
作者
Gomri, Farid [1 ]
Vischer, Solange [1 ]
Turzi, Antoine [1 ]
Berndt, Sarah [1 ,2 ]
机构
[1] Regen Lab SA, CH-1052 Le Mt Sur Lausanne, Switzerland
[2] Geneva Univ Hosp, Dept Plast Reconstruct & Aesthet Surg, Fac Med, CH-1205 Geneva, Switzerland
关键词
platelet-rich plasma; PRP; tissue regeneration; cell therapy; regenerative medicine; autologous biologics; ortho-biologics; hyaluronic acid; HA; good manufacturing practices; GMP; medical devices; PLATELET-RICH PLASMA; HYALURONIC-ACID; KNEE OSTEOARTHRITIS; GROWTH-FACTORS; CELLS; CLASSIFICATION; MACROPHAGES; LEUKOCYTE; OUTCOMES; RELEASE;
D O I
10.3390/pharmaceutics14081617
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Regenerative medicine, based on the use of autologous tissues and embryonic, stem or differentiated cells, is gaining growing interest. However, their preparation, in a manner compliant with good practices and health regulations, is a technical challenge. The aim of this manuscript is to present the design of reliable CE marked medical devices for the preparation of standardized platelet-rich plasma (PRP) and other autologous biologics intended for therapeutic uses. There are numerous PRP isolation processes. Depending on the methodology used, PRP composition varies greatly in terms of platelet concentration, platelet quality, and level of contamination with red and white blood cells. This variability in PRP composition might affect the clinical outcomes. The devices presented here are based on a specific technology, patented all over the world, that allows the precise separation of blood components as a function of their density using thixotropic separator gels in closed systems. This allows the preparation, in an automated manner, of leukocyte poor PRP with a standardized composition. Production of different forms of PRP is a clinical asset to suit various therapeutic needs. Therefore, we are offering solutions to prepare PRP either in liquid or gel form, and PRP combined with hyaluronic acid. These biologics have been successfully used in many different therapeutic domains, resulting in more than 150 published clinical studies. We also developed the CuteCell technology platform for cell culture expansion for further autologous cell therapies. This technology enables the safe and rapid in vitro expansion of cells intended for therapeutic use in good manufacturing practices (GMP) and autologous conditions, using blood-derived products as culture media supplementation. We summarize in this article our 20 years' experience of research and development for the design of PRP devices and, more recently, for PRP combined with hyaluronic acid.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Sources of Variability in Clinical Translation of Regenerative Engineering Products: Insights from the National Academies Forum on Regenerative Medicine
    Sarah H. Beachy
    Lakshmi Nair
    Cato Laurencin
    Katherine A. Tsokas
    Martha S. Lundberg
    [J]. Regenerative Engineering and Translational Medicine, 2020, 6 : 1 - 6
  • [32] Transition of molecular medicine from research into practice: tasks of the Swiss Academy of Medical Sciences
    Amstad, H
    Leuthold, M
    Scholer, D
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (46) : 1797 - 1802
  • [33] A Pilot Study on Result Reporting Rates from Clinical Trials of Regenerative Medicine
    Negoro, Takaharu
    Okura, Hanayuki
    Hayashi, Shigekazu
    Arai, Tsutomu
    Matsuyama, Akifumi
    [J]. TISSUE ENGINEERING PART B-REVIEWS, 2023, 29 (04) : 358 - 368
  • [34] Sources of Variability in Clinical Translation of Regenerative Engineering Products: Insights from the National Academies Forum on Regenerative Medicine
    Beachy, Sarah H.
    Nair, Lakshmi
    Laurencin, Cato
    Tsokas, Katherine A.
    Lundberg, Martha S.
    [J]. REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE, 2020, 6 (01) : 1 - 6
  • [35] The Utilization of Medical Devices by Traditional Korean Medicine Doctors Investigated through Traditional Korean Medicine Clinical Studies
    Sung, Soo-Hyun
    Sim, Hee-Ju
    Kim, Eu-Gene
    Sung, Angela Dongmin
    Park, Jung-Youn
    Shin, Byung-Cheul
    Park, Min-Jung
    Han, Chang Hyun
    Park, Jang-Kyung
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [36] A FRAMEWORK FOR IN SILICO CLINICAL TRIALS FOR MEDICAL DEVICES USING CONCEPTS FROM MODEL VERIFICATION, VALIDATION, AND UNCERTAINTY QUANTIFICATION (VVUQ)
    Bodner, Jeff
    Kaul, Vikas
    [J]. PROCEEDINGS OF THE 2021 ASME VERIFICATION AND VALIDATION SYMPOSIUM (VVS2021), 2021,
  • [37] From the field - Clinical use of medical devices in the 'Bermuda Triangle'
    Kessler, L
    Ramsey, SD
    Tunis, S
    Sullivan, SD
    [J]. HEALTH AFFAIRS, 2004, 23 (01) : 200 - 207
  • [38] Regenerative medicine - From stem cell biology to clinical trials for pediatric heart failure
    Peral, Susana Cantero
    Bernstein, Daniel
    Nelson, Timothy J.
    [J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 2016, 43 : 87 - 89
  • [39] Editorial: Adult stem cells for regenerative medicine: From cell fate to clinical applications
    Li, Jingting
    Luanpitpong, Sudjit
    Kheolamai, Pakpoom
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [40] From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives
    Sokal, E. M.
    [J]. CELL PROLIFERATION, 2011, 44 : 39 - 43